MARKET

TNGX

TNGX

Tango Therapeutics Inc
NASDAQ
12.89
+0.38
+3.04%
Pre Market: 12.51 -0.38 -2.95% 08:06 02/10 EST
OPEN
12.57
PREV CLOSE
12.51
HIGH
13.05
LOW
12.17
VOLUME
8
TURNOVER
0
52 WEEK HIGH
13.46
52 WEEK LOW
1.030
MARKET CAP
1.73B
P/E (TTM)
-13.9987
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TNGX last week (0202-0206)?
Weekly Report · 1d ago
Expert Outlook: Tango Therapeutics Through The Eyes Of 4 Analysts
Benzinga · 3d ago
Tango Therapeutics Is Maintained at Buy by Guggenheim
Dow Jones · 3d ago
Tango Therapeutics Price Target Raised to $18.00/Share From $12.00 by Guggenheim
Dow Jones · 3d ago
Guggenheim Maintains Buy on Tango Therapeutics, Raises Price Target to $18
Benzinga · 3d ago
Guggenheim Keeps Their Buy Rating on Tango Therapeutics (TNGX)
TipRanks · 4d ago
Tango Therapeutics CFO Daniella Beckman Reports Disposal of Common Shares
Reuters · 5d ago
Commit To Purchase Tango Therapeutics At $10, Earn 25.9% Annualized Using Options
NASDAQ · 5d ago
More
About TNGX
Tango Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering precision medicine for the treatment of cancer. The Company's novel small molecules are designed to be selectively active in cancer cells with specific genetic alterations, killing those cancer cells while sparing normal cells. It is also extending its target space beyond the classic, cell-autonomous effects of tumor suppressor gene loss. It is engaged in developing two methylthioadenosine (MTA)-cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors: TNG462 for non- central nervous system (CNS) cancers, including pancreatic and lung cancer, and TNG456, brain-penetrant PRMT5 inhibitor, for CNS cancers, including glioblastoma (GBM). Its TNG260 is a first-in-class Co-repressor of Repressor Element-1 Silencing Transcription (CoREST) inhibitor, which in preclinical studies reversed the immune evasion effect of STK11 loss-of-function mutations.

Webull offers Tango Therapeutics Inc stock information, including NASDAQ: TNGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNGX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TNGX stock methods without spending real money on the virtual paper trading platform.